Quantum Biopharma (QNTM) Share-based Compensation (2019 - 2026)
Quantum Biopharma (QNTM) posted Share-based Compensation of $892057.0 for Q1 2026, up 10.34% sequentially from $808452.0 in Q4 2025, and up 206.26% YoY from $291272.0 in Q1 2025.
Quantum Biopharma (QNTM) Share-based Compensation (2019 - 2026) Analysis & Trends
Quantum Biopharma has reported Share-based Compensation for 8 years, with the latest figure at $892057.0 in Q1 2026.
- Quarterly Share-based Compensation rose 206.26% year-over-year to $892057.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.5 million (up 819.34% YoY) and the FY2025 annual result came in at $2.9 million, up 1835.11% from the prior year.
- Share-based Compensation advanced to $892057.0 in Q1 2026 per QNTM's latest filing, from $808452.0 in the prior quarter.
- Over five years, Share-based Compensation peaked at $3.2 million in Q1 2023 and troughed at -$82477.0 in Q4 2024.
- A 5-year average of $550382.7 and a median of $355006.0 in 2022 frame the typical range for Share-based Compensation.
- The sharpest annual moves came in 2023 and 2024: Share-based Compensation surged 3755.82% in 2023, then slumped 182.99% in 2024.
- Over 5 years, Share-based Compensation stood at $506583.0 in 2022, then tumbled by 80.38% to $99384.0 in 2023, then plunged by 182.99% to -$82477.0 in 2024, then soared by 1080.22% to $808452.0 in 2025, then climbed by 10.34% to $892057.0 in 2026.
- According to Business Quant data, Share-based Compensation over the past three periods registered $892057.0, $808452.0, and $996194.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.52 Bn | 132.67 Bn | 2.84 Bn | 108.10 Mn |
| 2 | Regeneron Pharmaceuticals | 86.54 Bn | 78.55 Bn | 3.93 Bn | 243.00 Mn |
| 3 | Argenx Se | 65.31 Bn | 60.13 Bn | 1.37 Bn | - |
| 4 | Moderna | 61.77 Bn | 56.64 Bn | 52.00 Mn | 120.00 Mn |
| 5 | BeOne Medicines | 42.26 Bn | 37.16 Bn | 1.53 Bn | 137.41 Mn |
| 6 | Alnylam Pharmaceuticals | 31.19 Bn | 27.88 Bn | 992.69 Mn | 86.63 Mn |
| 7 | BioNTech SE | 28.71 Bn | 10.31 Bn | 668.28 Mn | 28.05 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 41.25 Mn |
| 9 | Royalty Pharma | 27.35 Bn | 26.52 Bn | - | - |
| 10 | Quantum Biopharma | 16.07 Mn | 12.43 Mn | - | 13,449.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 892,057.00 |
| Mar 31, 2026 | 892,057.00 |
| Dec 31, 2025 | 808,452.00 |
| Dec 31, 2025 | 808,452.00 |
| Sep 30, 2025 | 996,194.00 |
| Sep 30, 2025 | 996,194.00 |
| Jun 30, 2025 | 849,584.00 |
| Jun 30, 2025 | 849,584.00 |
| Mar 31, 2025 | 291,272.00 |
| Mar 31, 2025 | 291,272.00 |
| Dec 31, 2024 | -82,477.00 |
| Dec 31, 2024 | -82,477.00 |
| Sep 30, 2024 | 65,424.00 |
| Sep 30, 2024 | 65,424.00 |
| Jun 30, 2024 | 111,524.00 |
| Jun 30, 2024 | 111,524.00 |
| Mar 31, 2024 | 57,743.00 |
| Mar 31, 2024 | 57,743.00 |
| Dec 31, 2023 | 99,384.00 |
| Dec 31, 2023 | 99,384.00 |